Navigation Menu 

2022 Abstract Submission Rules & Format Guidelines for Students, Residents/Fellows and New Practitioners

DEADLINE: 11:59 pm CT – November 15, 2021To submit your abstract, visit tnpharm.org/submit-abstract-2022

Thank you for your interest in presenting at the 2022 TSHP Winter Meeting to be held on Sunday, February 27, 2022.

This document is to assist you in preparing your abstract submission to present a poster. To ensure that your abstract is considered for presentation, please read all instructions carefully.

Important Information

Deadline is November 15, 2021, 11:59 p.m. EST.  No exceptions. TPA will not edit abstracts. Incomplete submissions will be deleted.

  • You must currently be a member of TPA. Please note that membership is complimentary for fellows and residents.  Please contact tpa@tnpharm.org for more information.
  • Incomplete submissions will not be considered.
  • Primary Authors can only submit one abstract; however, they can be co-authors on other submitted abstracts.
  • You must be able to provide a link to a virtual platform (Zoom, GoToMeeting, Webex, etc.) that will be open for two hours to present your poster.
Poster Abstract Submission Requirements

Enter your poster abstract content details into the form fields on the TSHP poster presentation submission page.  Only completed submissions will be included in the review process.

Primary Author

  • First, Middle Initial (add a period), Last names, mailing address, contact information (i.e., phone and email address).
  • Professional information (i.e., position/title, employer, credentials, etc.). If you are a student, please enter graduation year and school.
  • Do NOT:
    • Use ALL CAPS
    • Place degrees in the “Last Name” field; add degrees in the credentials field

Additional Authors/Co-Authors

Each submission may have up to five (5) authors—the Primary Author and four (4) additional authors.  The Primary Author:

  • Must submit the names of additional authors by placing their names in the Additional Authors field on the submission form.
  • Ensures that all authors are listed in the order in which they appear on the abstract, citation, and poster display. TPA will not add “forgotten” authors or make changes to the order of the authors.

Title

Be sure your title accurately and concisely reflects the abstract content, as this title will be on all online and printed materials.

  • Please use sentence case to format your titles. Titles in all uppercase or lowercase letters will not be accepted.
  • Do NOT use proprietary (brand) names in the title.
  • Use capitalized letters only for acronyms or proper nouns (e.g., countries, etc.).
  • Do not use “A”, “An”, or “The” as the first word in the title.
  • Title Format Examples
    • Incorrect:  IMPLEMENTATION OF COMPUTERIZED PRESCRIBER ORDER ENTRY (CPOE) IN A SURGICAL UNIT: ONE YEAR LATER
    • Incorrect: implementation of computerized prescriber order entry (CPOE) in a surgical unit: One year later.
    • Correct: Implementation of computerized prescriber order entry (CPOE) in a surgical unit: One year later

Abstract

Your entire abstract should be limited to 3,000 characters with spaces and words (example below).

TitlePurposeMethodsResultsConclusion
150 characters500 characters1,000 characters1,000 characters350 characters
  • Spell out:
    • Special symbols ‐ Greek letters, degrees, plus and/or minus signs, greater-than or less-than signs, percentage, etc.  Use standard abbreviations.
    • All pharmaceutical acronyms.
  • Do NOT:
    • Use special functions such as tabs, underlines, trademarks, superscript, subscript, bold, or italics.
    • Include graphs, tables, or illustrations in your abstract.  
    • Include the title or authors in the body of the abstract.
  • Abstracts in outline form will be rejected.

Affirmation of Content

The Primary Author must affirm the content of the submission on behalf of all authors listed on the abstract.  Affirmation indicates that all co-authors are aware of the content and that an author, preferably the Primary Author, will present the poster during the meeting, if the abstract submission is accepted.

Conflict of Interest

The Primary Author must complete and electronically sign the conflict of interest agreement terms for the submission.  This includes agreeing to display the disclosures on the poster display.

Notifications

Responses of acceptance or denial will be emailed to the Primary Author no later than Wednesday, December 1, 2021.

A written notification is required by the Primary Author for all submission withdrawals.  Please send your withdrawal request to tpa@tnpharm.org.  If you withdraw after receiving your acceptance notice, we cannot guarantee that your presentation citation and/or abstract will not appear in print, on the TPA website, or in other electronic media.

Once your poster is accepted, you must register to attend the TSHP Winter Meeting by Friday, January 28, 2022. Anyone who does not register for the meeting by this date will forfeit the opportunity to present.